4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-23-022775
Chief Medical Officer sold 11,965 shares at $29.03 ($347,358)
- Chief Medical Officer acquired 11,965 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yeramian Patrick D Chief Medical Officer | 2023-05-15 | Option exercise 10b5-1 | +2,201 | $0.37 | $814 | 210,618 | D |
| Yeramian Patrick D Chief Medical Officer | 2023-05-15 | Option exercise 10b5-1 | +9,764 | $6.88 | $67,176 | 220,382 | D |
| Yeramian Patrick D Chief Medical Officer | 2023-05-15 | Sale 10b5-1 | −11,965 | $29.03 | $347,358 | 208,417 | D |
| Derivatives | |||||||
| Yeramian Patrick D Chief Medical Officer | 2023-05-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −2,201 | 15,404 | D | ||
| Yeramian Patrick D Chief Medical Officer | 2023-05-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −9,764 | 33,770 | D | ||
| Open-market sales · 11,965 sh · avg $29.03 · $347,358 | |||||||
Loading xslF345X04/ownership.xml…